VMP regimen

chemotherapy protocol consisting of the above compounds; used for treatment of non-Hodgkin's lymphoma; do not confuse with VMP or VMP-3 protocol

Networked: 8 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Therapy Context: Research Results

Therapeutics: 1158551
- Drug Therapy: 293145
  - Combination Drug Therapy: 12066
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - VMP regimen: 8
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - VMP regimen: 8
- Clinical Protocols
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - VMP regimen: 8
Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Polycyclic Aromatic Hydrocarbons: 2020
        Naphthalenes: 18
        Tetrahydronaphthalenes: 1
        Podophyllotoxin: 562
        Etoposide: 10706
        VMP regimen: 8
        Anthracenes: 12
        Anthrones: 12
        Anthraquinones: 788
        Mitoxantrone: 2907
        VMP regimen: 8
  - Halogenated Hydrocarbons: 42
    - Mustard Compounds: 3
      - Nitrogen Mustard Compounds: 2
        Chlorambucil: 1430
        Prednimustine: 111
        VMP regimen: 8
- Quinones: 434
  - Anthraquinones: 788
    - Mitoxantrone: 2907
      - VMP regimen: 8
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Naphthalenes: 18
    - Tetrahydronaphthalenes: 1
      - Podophyllotoxin: 562
        Etoposide: 10706
        VMP regimen: 8
  - Anthracenes: 12
    - Anthrones: 12
      - Anthraquinones: 788
        Mitoxantrone: 2907
        VMP regimen: 8
- Fused-Ring Compounds
  - Steroids: 70059
    - Pregnanes: 9
      - Pregnadienes
        Pregnadienetriols
        Prednisolone: 12013
        Prednimustine: 111
        VMP regimen: 8
Carbohydrates: 22023
- Glycosides: 2119
  - Glucosides: 639
    - Etoposide: 10706
      - VMP regimen: 8

Experts

1.	Palumbo, Antonio: 2 articles (06/2014 - 07/2011)
2.	Liu, Han-Yuan: 1 article (05/2019)
3.	Qian, Li-Li: 1 article (05/2019)
4.	Shen, Zhen: 1 article (05/2019)
5.	Song, Wei-Guo: 1 article (05/2019)
6.	Wang, Juan: 1 article (05/2019)
7.	Wei, Ying: 1 article (05/2019)
8.	Wu, Da-Bao: 1 article (05/2019)
9.	Zhang, Xue-Fen: 1 article (05/2019)
10.	Zhou, Ying: 1 article (05/2019)

Related Diseases

1.	Plasma Cell Leukemia 09/01/2010 - "Durable complete remission of primary plasma cell leukemia with the bortezomib plus melphalan and prednisone (VMP) regimen."
2.	Brain Neoplasms (Brain Tumor) 12/01/2004 - "[Sequential treatment of VmP regimen and whole brain radiotherapy for small cell lung cancer patients with brain metastases]." 12/01/2004 - "This study was designed to compare therapeutic effects,toxicities,and survival time of 2 different sequential treatments of VmP regimen and WBRT for SCLC patients with brain metastases. "
3.	Multiple Myeloma 01/01/2015 - "Bortezomib, Melphalan, and Prednisone (VMP) Regimen for Multiple Myeloma." 06/01/2014 - "Bortezomib plus melphalan and prednisone (VMP regimen) as the initial treatment for IgE multiple myeloma: a case study." 06/26/2014 - "Because interleukin-6 (IL-6) is considered important in the proliferation of early multiple myeloma (MM), we hypothesized that the addition of the anti-IL-6 monoclonal antibody siltuximab to the bortezomib-melphalan-prednisone (VMP) regimen would improve outcomes in transplant-ineligible patients with newly diagnosed MM. One hundred and six patients were randomized to receive 9 cycles of VMP or VMP plus siltuximab (11 mg/kg every 3 weeks) followed by siltuximab maintenance. "
4.	Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational) 05/01/2019 - "To evaluate the efficacy and toxicity of VMP regimen applied to the patients with low-risk gestational trophoblastic neoplasia (LR-GTN) treated in Anhui provincial hospital. " 05/01/2019 - "Low-risk gestational trophoblastic neoplasia outcome after treatment with VMP regimen from 2005 to 2017." 01/01/2019 - "The use of VMP regimen as the first line chemotherapy for low-risk gestational trophoblastic neoplasia." 05/01/2019 - "Between 2005 and 2017, 87 patients with low-risk gestational trophoblastic neoplasia received VMP regimen, consisted of vincristine (VCR), methotrexate (MTX) and platinum (cisplatin, carboplatin or nedaplatin), 68 of whom received VMP as their first-line chemotherapy, and 19 methotrexate-failed patients received VMP regimen as their second-line chemotherapy. "
5.	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/01/2004 - "[Sequential treatment of VmP regimen and whole brain radiotherapy for small cell lung cancer patients with brain metastases]."

Related Drugs and Biologics

1.	Bortezomib (Velcade)
2.	Prednisone (Sone)
3.	Melphalan (Alkeran)
4.	Therapeutic Uses
5.	Carboplatin (JM8)
6.	Interleukin-6 (Interleukin 6)
7.	Vincristine (Oncovin)
8.	Platinum
9.	Methotrexate (Mexate)
10.	Immunoglobulin E (IgE)

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Radiotherapy
3.	Aftercare (After-Treatment)